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ABSTRACT
As women age, the risk for being diagnosed with any gynecological cancer increases.
Despite outnumbering the number of breast cancer diagnoses in a given year, there are
significantly fewer studies addressing gynecological cancers. Treatment for
gynecological cancers can be incredibly debilitating, both physically and psychologically.
Although previous studies have evaluated and shown a relationship between physical
impairment and perceived control on psychological distress in cancer patients during
treatment, none have evaluated the influence of willingness and acceptance. The present
study sought to expand this theory by assessing 25 gynecological cancer participants via
self-report measures. Utilizing structural equation modelling, a moderated mediation was
conducted to evaluate the relationship between physical impairment and perceived
control on psychological distress, with willingness and acceptance serving as the
moderator for the mediation. Results, while not significant, found a favorable trend for
the model and suggest that future research and expanded data collection would further
indicate a strong association between the factors among women with gynecological
cancers.
KEYWORDS: ovarian cancer, gynecological cancer, uterine cancer, acceptance and
commitment therapy, acceptance and willingness, perceived control, physical impairment
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INTRODUCTION

Gynecological cancers as a group consist of five primary types: cervical, ovarian,
uterine/endometrial, vaginal, and vulvar cancers (Centers for Disease Control and
Prevention [CDC], 2018). An additional, sixth type is distinguished when cancer is found
in the fallopian tubes, although this subtype is rare, accounting for only 1-2% of all
gynecological cancers diagnosed (University of California San Francisco [UCSF], 2018).
Regardless, each presents its own unique issues and struggles affiliated with diagnosis,
treatment, and prognosis. Risk for any gynecological cancer increases as women age,
with most gynecological cancers being diagnosed between the ages of 40-70 years of age
(Furau, Dascau, Furau, Paiusan, Radu, & Stanescu, 2011).
While the number of gynecological cancer diagnoses is more than the number of
breast cancer diagnoses in a given year, there are far more research studies addressing
breast cancer than there are studies concerning gynecological cancers. While the strides
of breast cancer research are not to be disregarded, this significant gap in the literature is
concerning. Despite growing advancements and understandings of gynecological
cancers, they still “remain underfunded and under-researched,” with disparities across
demographics, such as race, socioeconomic status, and cancer type (Welch, 2017;
Collins, Holcomb, Chapman-Davis, Khabele, & Farley, 2014). Additionally, in a review
of the literature by Pearman (2003), it was found that gynecological cancer patients
experienced lower quality of life during treatment, when compared to breast cancer
patients undergoing treatment. This appeared to be due to the differences in treatment
intensity, age, and a lacking social support.
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Cervical Cancer
Despite the estimated 13,240 new cases of invasive cervical cancer that will be
diagnosed in 2018, between 1975 and 2014, the incidence rate has declined by more than
half (American Cancer Society [ACS], 2018). This decline has been attributed to a rise
in screening measures, primarily through the Pap test. It is important to note, however,
that this declining rate has begun to slow in more recent years. In 2018, the predicted
number of deaths from cervical cancer is over 4,000. While the majority of cervical
cancers are attributed to certain strains of the human papillomavirus (HPV), HPV
infections are fairly common in most women and rarely develop into cancer. The fiveyear survival rate for cervical cancer varies depending on the cancer diagnosis, with a
92% survival rate for the 46% of those diagnosed with localized cervical cancer; and 17
to 57% for those diagnosed with distant-stage or regional disease (ACS, 2018).
Treatment also varies depending on the severity of the disease. A loop
electrosurgical excision procedure (LEEP), cryotherapy, laser ablation, or conization are
commonly utilized to remove abnormal tissue in precancerous cervical lesions (ACS,
2018). Along with chemotherapy, surgery and radiation are often used to treat more
invasive or advanced stages.

Vaginal and Vulvar Cancers
Often discussed and addressed together, vaginal cancer and vulvar cancer only
account for approximately 6 to 7% of all gynecological cancers diagnosed (Centers for
Disease Control and Prevention [CDC], 2016a). While diagnosis of these cancers is rare,
a history of HPV, cervical cancer, weakened immune system, and smoking can put
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women at an increased risk of vaginal or vulvar cancer. It is also worth noting that the
Pap test does not cover the screening of vaginal and vulvar cancers, although most
physicians will screen for these cancers following an abnormal Pap test for cervical
cancer. The average number of deaths for vaginal and vulvar cancers are over 4,000 and
5,000, respectively (Foundation for Women’s Cancer, 2018).
To treat vulvar cancer, simple procedural surgeries, such as laser surgery or
excision, are often employed to remove the abnormal tissue. More extensive surgeries,
such as a vulvectomy, vulvar reconstruction, pelvic exenteration, and/or lymph node
surgery, are utilized only to treat more advanced stages, along with possible
chemotherapy and radiation. Similarly with treatment of vaginal cancers, laser surgery
and topical treatments are utilized for early stage vaginal cancer with more invasive
forms being treated with surgery, radiation, and chemotherapy. Regardless of the
treatment plan, in today’s medical care the efforts to sustain quality of life and sexuality
are prioritized as appropriate in relation to cancer stage.

Uterine Corpus (Endometrium) Cancer
Commonly referred to as endometrial or uterine cancer, uterine corpus cancer is
diagnosed when malignant cells are found in the body of the uterus, with the majority of
cases found in the endometrium or lining of the uterus (CDC, 2018). It is estimated that
in 2018, over 63,000 new cases of uterine cancer will be diagnosed, with the incidence
rate showing a 1-3% increase per year between 2005 and 2014, making it the most
commonly diagnosed gynecological cancer (ACS, 2018). The death rate for uterine
cancer has also increased between 1-2% each year from 2006 to 2015, with an estimated
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over 11,000 expected to die in 2018. The five-year survival rate, however, is between 62
and 84%, with most cases of uterine cancer being diagnosed in early stages due to
unexpected, postmenopausal bleeding.
Treatment for uterine cancer heavily revolves around the factors of cancer stage
and fertility in patients (ACS, 2018). Earlier stages of the cancer are often treated with
surgery and/or radiation and chemotherapy, however for young women still desiring
fertility options, progestin therapy is often utilized. Progestin therapy involves the
ingestion or injection of progestin in order to shrink or eliminate cancer cells, thus saving
future fertility options, although this method is often regarded as “experimental” and
“risky.” More advanced stages of uterine cancer, which have spread to other lymph
nodes, are typically unable to be removed by surgery and thus require extensive radiation
and hormone therapies. This treatment, as is consistent with most invasive forms of
gynecological cancer, involves significant physical and functional impairments, including
lower limb lymphedema, general pain, fatigue, pelvic issues, and other associated issues
(Hammer, Brown, Segal, Chu, & Schmitz, 2014). In a study evaluating the relationship
between physical impairment and physical activity in uterine cancer survivors, those who
reported higher rates of physical and functional impairments, were less likely to engage
in physical activity.

Ovarian Cancer
While Ovarian cancer accounts for only three percent of all cancers diagnosed,
due to the aggressive nature and insufficient methods of early detection, it is the fifth
leading cause of cancer death in women (Center for Disease Control [CDC], 2016b). It
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also holds the highest mortality rate amongst all gynecological cancers, despite being the
second most common (Foundation for Women’s Cancer, 2018). In 2018, it is estimated
over 22,000 women will be diagnosed with ovarian cancer (ACS, 2018). Within the same
year, over 14,000 are predicted to die from the disease. This high death rate may be
attributed to the fact that the majority of women who are diagnosed with ovarian cancer
are diagnosed with advanced/metastasized disease. The five-year survival rate for these
advanced stages ranges from only 29 to 47% (ACS, 2018).
Treatment typically includes a debulking surgery to remove as much of the tumor
as possible, followed by chemotherapy with a combination of cisplatin or carboplatin and
taxane or docetaxel agents (ACS, 2016a). The goal of this procedure is to induce a
disease-free remission of the cancer for as long an interval as possible (Stevinson et al.,
2009). Despite the treatment, approximately 75% of women with stage III or IV disease,
in which the cancer has spread to the lymph nodes and/or outside the peritoneal cavity,
have a recurrence in less than two years (ACS, 2016b; Jemal et al., 2009; Markman et al.,
2001 as cited in Ponto, Ellington, Mellon, & Beck, 2010). The recurrence is typically
followed by a return to the chemotherapy regimen, and perhaps an interperitoneal
administration of the agents, with the goal of gaining another period of remission.
Typically, this process continues, along with decreasing functional daily activity and
increasing side effects, such as nausea and vomiting, abdominal pain, headaches, fatigue,
etc., until remission is no longer achievable and/or the patient determines they do not
wish to continue with chemotherapy.
Given this difficult process, it is not surprising that previous authors have noted
that the “relentless nature of the disease and treatment…suggests that adjustment to this
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experience may pose significant physical and emotional challenges.” (Ponto et al., 2010,
p. 357). And in fact, data supports this, with reported rates of psychological distress
ranging from 23%to 33% (Norton et al., 2004; Kornblith et al., 1995). Even greater, the
occurrence of clinical depression specifically, has been reported in 55% of women in
treatment (Norton et al., 2004).
When evaluating the circumstances surrounding these reports, a review of the
literature by Arden-Close and colleagues (2008) examining predictors of distress
indicates that higher rates of depression and anxiety are often found among younger
women (Strong et al., 2007), those with perceived poor social support (Stewart, Wong,
Duff, Melancon, & Cheung, 2001; Norton et al., 2005), those with more advanced
disease (Boscaglia et al., 2005; Kornblith et al., 1995), and those with greater physical
impairment (Norton et al., 2005; Kornblith et al., 1995). The comparative strength of
these variables, and how these predictors may interact with regard to distress, however, is
unknown.

Physical Impairment
One predictive variable that has been evaluated is the impact of physical
impairment. Physical impairment in cancer patients has been defined as the degree of
difficulty in limitations in one or more daily living activities, due to the side effects of
both the treatment and disease itself (Kornblith et al., 1995; Arnold, 1999). Advanced
gynecological cancers and their treatments tend to have significant deleterious effects for
patients. Recovery from surgical procedures, such as debulking the tumor, results in
dramatic loss of abdominal and core strength, thus impacting many movements required
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to complete daily activities. Chemotherapy, and the cancer itself, contribute significantly
to overall weakness, cognitive decline, peripheral neuropathy or nerve damage,
abdominal blockages, and ascites or fluid in the abdomen. As a result, the majority of
gynecological cancer patients endorse suffering from some degree of physical
impairment during their treatment.
Physical impairment has also been associated with increased rates of anxiety and
depression, as well as lower self-esteem (Norton et al., 2005; Simonelli, Fowler,
Maxwell, & Andersen, 2008) among patients with gynecological cancers. In fact,
according to prospective studies, physical impairment is the strongest predictor of overall
psychological distress throughout the course of ovarian cancer (Kornblith et al., 1995). In
a study evaluating physical impairment and symptoms of depression in gynecological
cancer survivors, those who reported higher physical impairment also reported “lower
levels of meaning in life,” and a higher number of depressive symptoms (Simonelli et al.,
2008). This indicates that as women experience increasing pain, mobility limitations,
fatigue, and sickness that interferes with their ability to engage in their typical activities
and to function independently in completing activities of daily living, they tend to be
increasingly distressed and emotionally disturbed, no matter what stage of disease
progression or overall prognosis.

Perceived Control
Alternatively, researchers have noted that individuals tend to have better
psychological adjustment when they perceive that they have the ability to achieve
positive and avoid negative outcomes through their own actions, also known as personal
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perceived control (Thompson & Collins, 1995). The context of cancer, however, has been
described as a low-control situation (Ranchor et al., 2010), thus leading to questions of
the effect of perceived control when little control exists. This may easily be applied to
coping with physical impairments and emotional stressors experienced while managing
gynecological cancers. Despite what may be uncontrollable (the disease, side effects,
etc.), a broadly defined perceived control is positively related to improved psychological
outcomes among individuals with cancer (Osowiecki & Compas, 1999; Thompson,
Sobolew-Shubin, Galbraith, Schwankovsky, & Cruzen, 1993)
Coinciding with this concept, a predictive and unsurprising relationship appears to
exist between physical impairment, perceived control, and distress. Among patients
diagnosed with breast cancer and undergoing initial treatment, researchers identified a
linear relationship showing that as patients recover from breast cancer surgery, their
levels of perceived control increased, as their reported distress decreased (Barez, Blasco,
Fernandex-Castro, & Viladrich, 2009). This suggests that as patients recover and their
impairment decreases, they feel more in control and thus less distressed. For patients who
do not regain a sense of control, the physical impairment appears to negatively impact
their emotional state, and distress continues to increase (Ranchor et al., 2010). While this
trajectory may occur among women being treated for breast cancer, the recovery
trajectory is likely different for women being treated for gynecological cancers. Empirical
study of the relationship among these variables (impairment, perceived control, and
distress) among ovarian patients specifically, previously revealed a mediation, such that
the direct relationship between impairment and distress, was mediated by the patient’s
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perceived control (Norton et al., 2005). Figure 1 provides a visual example of this
mediation as reported by Norton et al. (2005).

Willingness and Acceptance
Given the limited control affiliated with a cancer diagnosis and treatment journey,
an alternative to perceived control and the need for control is an open willingness and
acceptance stance. The theory and foundation of Acceptance and Commitment Therapy
(ACT; Hayes, Strosahl, & Wilson, 1999) posits that perceived control, and the perceived
need for control, is a major contributor to the development of psychological distress
across a variety of settings and populations (Gundy, Woidneck, Pratt, Christian, &
Twohig, 2011).
Research has repeatedly shown that individuals experiencing cancer who cope
through acceptance have better psychological adjustment and less distress as compared to
those who cope through cognitive and behavioral control attempts (Low, Stanton,
Thompson, Kwan, & Ganz, 2006). For example, women with breast cancer who score
higher on measures of acceptance have less emotional distress than those who are less
accepting (Stanton, Danoff-Burg, & Huggins, 2002). This is a robust finding that is
consistent in cross sectional measures and prospective measures (Stanton & Snider,
1993). This finding has also been echoed in similar studies evaluating women
undergoing treatment for a gynecological cancer, in which those who utilized greater
acceptance and positivity techniques reported better functional and emotional well-being
over time, especially when compared to those who utilized avoidant coping strategies and
denial (Lutgendorf et al., 2002; Gould, Brown, & Bramwell, 2010). Similarly,
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psychological interventions that target acceptance are associated with improved
psychological outcomes among women coping with advanced cancer (Rost et al., 2012).
Within the ACT model, acceptance does not represent a resolve or ‘giving up,’
but rather a willingness to have, be, and experience what is, while continuing to strive for
health and quality of life. This is often in opposition to the desire and effort that may be
exerted to control one’s reactions, feelings, and emotions in regards to what is present
and their current experience. When evaluating coping strategies in women during
treatment for gynecological cancer, those who had higher physical impairment and
complications during treatment, led to lower satisfaction and the increased utilization of a
helplessness-hopelessness coping tactic (Bucholc, Kucharczyk, Kanadys, Wiktor, &
Wiktor, 2016). Thus, showing that the higher the physical impairment, the higher lack of
perceived control over treatment, the lower satisfaction and ability to cope by more
effective, positive means.

Hypotheses
Given this model and the empirical support of this model, we suggest that it is not
just perceived control that is an important mediator, but that a patient’s acceptance and
willingness plays an important role in better understanding the relationships between
physical impairment, perceived control and psychological distress. The purpose of the
current study is to build on the previously presented model and examine the interplay of
these variables using a cross sectional design, with data obtained from women who have
been diagnosed with a gynecological cancer.
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Specifically, the intent is to test a hypothesized model in which willingness
functions as a moderated mediator in the previously reported model, in which perceived
control mediated the effect between physical impairment and psychological distress. It is
expected that for patients with high physical impairment, who are emotionally and
psychologically willing to experience the current impairment, perceived control will
make less of a contribution in determining psychological distress.
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METHODS

Participants
In total, 25 women completed the study’s questionnaires via self-report. Of the
participants, 15 were diagnosed with ovarian cancer, 6 were diagnosed with endometrial
cancer, and 4 were diagnosed with uterine cancer. The majority of participants were
currently undergoing some form of treatment, such as chemotherapy, radiation, surgery,
or hormone therapy. 6 participants were in the remission stage of the disease, while the
remaining participants were diagnosed with a range from Stages I-IV. The number of
days since diagnosis, at the time of completing the survey, ranged from 40-3536 days
(approximately 9 years and 8 months), with an average of 1241 days (approximately 3
years and 4 months).
Participant age ranged from 31-76 with an average age of 50.76 years. The
average level of education received was a college degree, while the average household
income was $84,273. 19 of the participants identified as being married, 3 identified as
being divorced, and 3 identified as single. The majority of participants identified as
Caucasian/White, while 2 identified as Latino. Table 1 comprehensively presents
demographic and medical data collected.

Procedure
Approval from the Missouri State University IRB was obtained prior to
participant recruitment (IRB-FY2018-309; Appendix A). Participants were recruited
through online support groups for those diagnosed with gynecological cancer. Group
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administrators were contacted with information regarding the study, a digital flyer, and a
URL link to the study questionnaires. Of those contacted, 25 women participated (N =
25). The inclusion criteria were: (a) primary diagnosis of a gynecological cancer, Stages
I-IV or In Remission, (b) the patient is undergoing or has undergone treatment for
gynecological cancer, (c) the patient is at least 18 years of age or older, and (d) the
patient is proficient in English language reading and writing. All participants were asked
to provide consent before being able to proceed to the survey questionnaires.

Measures
Demographics. Information regarding demographics included the patient’s age,
date of diagnosis, cancer stage, treatment stage, race/ethnicity, education level, marital
status, employment status, and average household income (See Appendix B).
Psychological Distress. Psychological distress was measured by assessing
depression and anxiety related symptoms. Depression related symptoms were evaluated
using the Center for Epidemiologic Studies Depression Scale (CES-D α = .85-.90;
Radloff, 1977; See Appendix B). Anxiety related symptoms were evaluated using the
Generalized Anxiety Disorder 7-item scale (GAD-7 α = .89; Spitzer, Kroenke, Williams,
& Lowe (2006); Lowe et al., 2008; See Appendix B).Participants answered the 20question and 7-question, respectively, assessments, with higher scores corresponding to
higher severity. Both scales utilized a 0-3 ranking system and corresponded accordingly.
Scores from each were combined to create a total psychological distress score.
Physical Impairment. In order to evaluate patients’ ability to perform daily
activities and the degree of difficulty performing daily tasks, the Cancer Rehabilitation
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Evaluation System Short Form for Research (CARES-SF α = .70; Coscarelli & Heinrich,
1988) was used (See Appendix B). The first 10 items of the CARE-SF, which pertain to
physical impairment, were utilized for data analysis purposes to assess the identified
variable. High scores related to higher impairment
Perceived Control. Consistent with previous studies evaluating perceived
control (Thompson et al., 1993; Norton et al., 2005), participants were asked to rate their
perception of control over the following items: emotions, physical symptoms, medical
treatment, medical information, progression of disease, physical activity, and overall.
Participants answered the question “To what extent do you feel that you have control
over…?”, followed by the listing of the above mentioned items (See Appendix B). The
corresponding scale included 4 points ranging from 1 (no control at all), 2 (very little
control), 3(some control), to 4 (a great deal of control).
Willingness and Acceptance. The factors associated with the ACT principles of
willingness and acceptance were evaluated through the Acceptance & Action
Questionnaire (AAQ-II α = .91; Hayes et al., 2004; See Appendix B). The traditional 7item scale questions were utilized for this particular analysis, although an additional 3
reverse score items from the 10-item AAQ-2 were collected. The measure utilizes a 7point scale, with higher scores indicating “greater levels of psychological inflexibility
(Bond et al., 2011).” For the purpose of interpretation of statistical analyses, this
suggests that lower AAQ-2 scores indicate lesser influence of external variables over
time, thereby indicating more willingness and acceptance.
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RESULTS

Preliminary Analysis
Prior to analysis, data screening confirmed that the data was accurate. 2
participants were revealed to be missing 2 values for the CES-D questionnaire each, and
thus, following the less than 5% standard for replacement, these values were replaced
using linear trend at point. When taking into consideration the number of participants
included in the study (N= 25), the data met all assumptions for normality,
multicollinearity, homogeneity, and homoscedasticity. No multivariate outliers were
found. Table 2 presents a summary of the means for the variables of concern, physical
impairment, perceived control, psychological distress, and willingness and acceptance.
All analyses were completed using R-stats statistics program.

Analysis of Cancer-Related Variables
In order to evaluate the relationship between the disease-related variables of
cancer type, stage, and treatment, on primary variables of concern for this project,
psychological distress, physical impairment, willingness and acceptance, and perceived
control, 12 one-way between subjects ANOVAs were analyzed. Psychological distress
did not reveal significant relationships for cancer type (F(2,22) = 0.96, p = .40, η2 = .08),
stage (F(4,20) = 0.92, p = .47, η2 = .16), or treatment phase (F(4,20) = 0.25, p = .90, η2 =
.05). The willingness and acceptance variable also did not reveal significant relationships
for cancer type (F(2,22) = 1.01, p = .38, η2 = .08), stage (F(4,20) = 0.14, p = .96, η2 =
.03), or treatment phase (F(4,20) = 2.75, p = .06, η2 = .35). Additionally, perceived
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control did not yield significant relationships for cancer type (F(2,22) = 0.50, p = .61, η2
= .04), stage (F(4,20) = 1.31, p = .29, η2 = .21), or treatment phase (F(4,20) = 1.77, p =
.17, η2 = .26). A lack of significance is believed to be attributed to low N.
Physical impairment did not yield significant results for the relationship with
cancer type (F(2,22) = 0.15, p = .86, η2 = .01), or treatment (F(4,20) = 0.43, p = .78, η2 =
.08). The relationship between physical impairment and cancer stage, however, did
indicate a significant relationship (F(4,20) = 3.86, p = .01, η2 = .44). Post-hoc analyses
using independent t-tests with Bonferroni correction was used to examine differences
between individual groups and revealed significant differences between the Stage II (M =
17, SD = 5.29) and Stage IV (M = 32.33, SD = 5.86), t(4) = -3.36, p = 0.03, d = -2.75,
95%CI[-5.12 - -0.25] groups and between the groups of Stage IV (M = 32.33, SD = 5.86)
and remission (M = 19.67, SD = 5.13), t(7) = -3.35, p = 0.04, d = -2.37, 95%CI[-4.16 - 0.48]. This indicates that Stage IV entails significantly more physical impairment when
compared to participants with Stage II cancer or participants in remission.

Perceived Control as a Mediator Between Physical Impairment and Psychological
Distress
Drawing on the Norton et al., (2005) study as a model for this study, the same
analysis of the relationship between physical impairment and distress, utilizing perceived
control as a mediator, was analyzed for this study. Figure 2 illustrates the visual
representation of the completed model for the current study. Analysis of the
predictability of physical impairment on psychological distress (the c pathway), revealed
a positive relationship between the two variables, b = 0.46, t(23) = 1.18, p = .25. The
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ability of physical impairment to predict perceived control (the a path) showed a negative
relationship between the variables, b = -0.21, t(23) = -2.13, p = .002. Thus, as physical
impairment increases, perceived control decreases. Finally, the relationship between the
mediator of perceived control and the variable of psychological distress indicated a
significant, negative relationship, b = -2.50, t(23) = -4.09, p <.001. This indicates that as
perceived control decreases, psychological distress increases. While the sample size
limits the interpretation of the results, given that the Sobel test (Z = 1.42, p = .16), and
Confidence Interval calculations of path effects (total effect= .62; direct effect= -.09;
indirect effect= .54) were nonsignificant, the analysis does show a desired general trend
in the hypothesized direction. Given that the value of the indirect effect would indicate a
strong mediation, confidence intervals were calculated for the indirect effect using
bootstrapping (R= 1000), 95% CI [-0.12, 1.14]. By comparison to the model’s other
pathways, analysis suggested that perceived control as a mediator for physical
impairment yielded a strong, inverse relationship to the y-value of psychological distress.
Thus, as physical impairment increases, perceived control decreases, and psychological
distress increases, and vice versa. Statistical summaries for all mediation pathways of the
variables is included in Table 3.

Willingness and Acceptance as a Moderator for the Mediation between Physical
Impairment, Perceived Control, and Psychological Distress
To address the primary focus of the study, the associations between physical
impairment, perceived control, and psychological distress, with willingness and
acceptance serving as a moderator for the mediation was analyzed. Figure 3 illustrates
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the visual representation of the completed model. Again, while the sample size limits the
interpretation, the trend of the analysis is promising. The overall model’s interaction was
not found to be significant, F(4, 20) = 5.17, p = .005, R2 = .51. Output for the not
significant relationship between physical impairment and psychological distress (the c
pathway) and the significant relationship between physical impairment and perceived
control (the a path) were consistent with the previous mediation analysis. These
relationships suggest that as physical impairment increases, psychological distress
increases and, separately, that as physical impairment increases, perceived control
decreases. The relationship between the variables of perceived control and psychological
distress was found to be significant, b = -1.93, t(20) = -2.56, p = .02. Thus, as perceived
control increases, psychological distress decreases. While the c’ pathway was not
significant, the inclusion of the mediator (perceived control) and moderator (willingness
and acceptance) variables did affect the relationship from positive to negative, b = -0.15,
t(20) = -0.44, p = .66, indicating that the moderator has an inverse effect. Analysis of the
variable of willingness and acceptance as a moderator for the mediation did not yield a
significant result, b = 0.35, t(20) = 1.28, p = .21, but suggested that as psychological
inflexibility increases, psychological distress increases as well. Simple slopes were
calculated only to determine the indirect effects of the moderator (W) which resulted in
changes at varying levels, further indicating that the interaction was not significant due to
a low N. Thus, as the moderator, AAQ-2 scores, increases, the relationship between the
mediator of perceived control and the variable of psychological distress decreases in
strength. Confidence Intervals for the indirect effects were calculated using
bootstrapping (R= 1000). Indirect effect size for average willingness and acceptance
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scores was 0.41, 95% CI [-0.11, 1.14]. Low scores, indicating greater willingness and
acceptance, indirect effect was estimated as 0.50, 95% CI [-0.11, 1.09], and high scores,
indicating lower willingness and acceptance, had an estimated indirect effect of 0.31,
95% CI [-0.32, 0.90].
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DISCUSSION

Summary
Despite statistical analysis of the data showing a general lack of significance in
the studied relationship, the general trend of the data did indicate some support to the
hypothesized model. Overall, this study indicated a relationship between the variables of
physical impairment and psychological distress, physical impairment’s and perceived
control’s impact over psychological distress, and a relationship between willingness and
acceptance in addition to physical impairment and perceived control over psychological
distress. These findings provide further support to the literature and present newer
findings to be further explored when expanding the knowledge of gynecological cancers.
This study was also able to provide insight regarding cancer-related variables, such as
cancer type and stage, in relation to the measured variables. Thus, these findings provide
insight into the relationship between the variables and the support for future, more
thorough analyses to be conducted.

Data Limitations
It is important, however, to note the limitations involved with this study. First
and foremost, the small number of participants does not allow for the analysis to be
thoroughly vetted in order to determine a more appropriate significance value for the
relationship. Thus, this analysis can, at best, be categorized as an exploratory study to
support future, more expansive research on the relationship. Expanding the study’s reach
is crucial to a more thorough analysis of the relationship, but it may also be ideal to
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conduct this study in more targeted, local areas in order to gain access to better followup. Formal introduction and exit interviews may need to be utilized, when applicable, to
gain a better assessment of the impact of the study.
Additionally, while the identified factors, variables, and measures for this analysis
were the focus of this particular hypothesized model, there were other variables and
measures collected that have not yet been analyzed. Future analysis regarding
personality, mood, and other potential factors’ impact on the ability to cope with
gynecological cancers may provide further insight into the relationship. Reviews of the
current literature and these factors would also need to be conducted.

Proposed Future Application
Practical application for these findings would point toward possible areas of focus
during treatment in order to alleviate some psychological distress in gynecological cancer
patients. Physical activity often changes during the course of cancer treatment, and
specifically among women undergoing the difficult treatment of surgery and adjuvant
treatment for gynecological cancer. Data suggests that in the first year following the
diagnosis, almost 40% of women with ovarian cancer decrease their level of physical
activity (Beesley et al., 2011). This is problematic, given that physical activity has been
shown to be related to better psychological outcomes and coping among individuals
undergoing treatment for cancer (Faul et al., 2011), as well as less physical impairment
(Ligibel et al., 2010; Wu, Dodd, & Cho, 2008). Alternatively, decreased physical activity
is often associated with more reports of depression and decreased quality of life (Beesley
et al., 2011).
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Despite the fact that implementing physical activity interventions is complicated
with individuals with illness, 84% of patients with metastatic breast cancer have reported
that they would be interested in an exercise program that could be done in their home
(Lowe, Watanabe, Baracos, & Courneya, 2010). Among ovarian cancer patients, 53%
reported that they would be interested in participating in a physical activity program
(Stevinson et al., 2009). In both cases, the women endorsed preference toward light
impact activity, such as walking, and to be in a small group with people they knew (Lowe
et al., 2010; Stevinson et al., 2009). Although intervention studies have not been
conducted with gynecological cancer patients, research conducted with patients
diagnosed with advanced metastatic breast cancer indicate that interventions that lead to
increased physical activity produce improved physical functioning and decrease fatigue
(Oldervoll et al., 2006; Headley, Ownby, & John, 2004). These studies further suggest
that even light physical activity has the capacity to slow the development of physical
impairment that is experienced by these patients.
Past research has largely focused on the role of self-efficacy, as opposed to
perceived control, when considering variables from the Health Benefit Model in relation
to physical activity. The Health Belief Model (Hochbaum, 1958) provides explanation
and prediction for health-related behaviors. This model demonstrates that an individual’s
self-efficacy, perceived threat or susceptibility, perceived benefits versus perceived
barriers, and cues to action will influence the likelihood to engage in health-related
behaviors. These factors, however, typically address behaviors affiliated with prescreening or preventative steps, thus increasing the perception of control. In relation to
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our model, we believe increased activity would impact perceived control of an
uncontrollable situation, which appears to be associated with less distress.
Future research may evaluate this relationship within our proposed model, by
incorporating physical activity during cancer treatment. Yoga, a commonly
recommended form of light impact physical activity, has been evaluated extensively in
various populations of chronic illness and cancer, but not in gynecological cancers
(Bosch, Traustadottir, Howard, & Matt, 2009; Rogers & Macdonald, 2015;
Fouladbakhsh, Davis, & Yarandi, 2014; Buffart et al., 2012; Duncan, Leis, & TaylorBrown, 2008; Danhauer et al., 2009; Danhauer et al., 2008; Lowe, Watanabe, Baracos, &
Courneya, 2012; Smith & Pukall, 2009; Levine & Balk, 2012). Additionally, the impact
of healthier lifestyle choices, including better diet and regular physical activity, has also
been linked to help reduce the rate of telomere shortening in the overall population, as
well as during treatment for cancer patients (Garland et al., 2014a; Garland et al., 2014b;
Shammas, 2011). Telomeres are the genetic material located at the ends of chromosomes
in order to protect the genetic data in cells as they divide (Shammas, 2011). As humans
age, telomeres shorten, which increases the risk of developing cancer (Wong & Collins,
2003). This is all referenced to show that there are many working parts to this theory
and study. The need for future research in these areas and within this model is imperative
as the field moves forward with understanding and assisting gynecological cancer
patients as they cope and in order to increase patients’ overall quality of life.
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Appendix B. Measures
Appendix B-1 Demographic Information
Participant No.:______________________
Age:
Race/Ethnicity:
Caucasian/White
Islander
Hispanic or Latino
______
Education level:
Less than High School
Graduate
Graduate School
Marital Status:
Single

African American/Black

Asian/Pacific

Native American or American Indian

High school graduate

Married

Other: _

Some College

Divorced/Separated

College

Other:

Average Household Income:
Date of Diagnosis:
Disease Stage:
Stage I
Remission

Stage II

Stage III

Treatment Stage:
Pre-surgery
Post-surgery
Treatment
No Current Treatment
Other:
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Stage IV

Chemotherapy

Recurrent disease

Radiation

Appendix B-2 Center for Epidemiologic Studies Depression Scale (CES-D)
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34

Appendix B-3 Generalized Anxiety Disorder (GAD-7) Scale.
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Appendix B-4 Cancer Rehavilitation Evaluation System Short Form (CARE-SF).
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37

38

39

40
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Appendix B-5 Perceived Control Questionnaire
Please rate the following:
To what extent do you feel that you have control over…
No control at all Very little control Some Control A great deal of
control
Your Emotions?
1
2
3
4
Physical Symptoms?

1

2

3

4

Medical Treatment?

1

2

3

4

Medical Information?

1

2

3

4

Progress of your cancer? 1

2

3

4

Physical Activity?

1

2

3

4

Overall?

1

2

3

4
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Appendix B-6 Acceptance & Action Questionnaire (AAQ-2)
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TABLES

Table 1. Demographic Data Summaries
Descriptive Statistics of Participant Demographic Data
Variable

N

M

Age

21

50.76

31-76

84273

24000-300000

1241

40-3536

Race

Caucasian/White
Hispanic/Latino

25
23
2

Education
High School Graduate
Some College
Two-Year College Degree
Four-Year College Degree
Professional Degree

25
2
7
4
7
5

Marital Status
Married
Divorced
Single

25
19
3
3

Average Household Income

22

Primary Cancer Diagnosis
Ovarian
Uterine
Endometrium

25
16
4
6

Disease Stage
Stage I
Stage II
Stage III
Stage IV
Remission

25
5
3
8
3
6

Treatment Stage
Chemotherapy
Post-surgery
Radiation
No Current Treatment
Other
Days Since Diagnosis*

25
4
5
1
5
9
25

*From date of survey completion
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Variance

Table 2. Table of Means for the Studied Variables.
Descriptive Statistics of the Variables
M

SD

Physical Impairment

23.16

6.61

Perceived Control

19.56

3.50

Psychological Distress

32.84

12.56

Willingness and Acceptance

22.6

9.17

Variable

Table 3. Model Summaries for Mediation Analysis.
Mediation Model Summaries
Model

F

p

R2

Physical Impairment predicting Psychological
Distress

(1, 23) = 1.40

.25

.06

Physical Impairment predicting Perceived
Control

(1, 23) = 4.52

.04

.16

Physical Impairment and Perceived Control
predicting Psychological Distress

(1, 22) = 9.52

.001

.46
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FIGURES

Figure 1. Model of the Mediation Analysis from Norton et al. (2005).

Figure 2. Completed Model of the Mediation. The figure illustrates the completed model
for the current study, showing the relationship between physical impairment and
psychological distress (c pathway; b = .46). The relationship between physical
impairment and perceived control as the mediator (a pathway; b = -.21) and the
relationship between perceived control and psychological distress (b pathway; b = -1.93).
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Figure 3. Completed Model of the Moderated Mediation. The model illustrates the
relationship between physical impairment and psychological distress, with (c pathway; b
= .46) and without (c’ pathway; b = -.15) the moderator. The relationship between
physical impairment and perceived control as the mediator (a pathway; b = -.21) while
willingness and acceptance serves as a moderator (b pathway; b = -1.93).
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